Axis Capital (NYSE: AXS) has recently received a number of price target changes and ratings updates: 11/2/2026 – Axis Capital was given a new $123.00 price target by Mizuho. 11/2/2026 – Axis Capital had its price target raised by Wells Fargo & Company from $112.00 to $122.00. They now have an “overweight” rating on the […]

Several analysts have recently updated their ratings and price targets for CenterPoint Energy (NYSE: CNP): 10/29/2026 – CenterPoint Energy had its “buy” rating reaffirmed by Jefferies Financial Group. 10/28/2026 – CenterPoint Energy was given a new $43.00 price target by Mizuho. 10/28/2026 – CenterPoint Energy had its price target raised by Barclays from $41.00 to […]

A number of research firms have changed their ratings and price targets for Arrowhead Pharmaceuticals (NASDAQ: ARWR): 10/15/2026 – Arrowhead Pharmaceuticals is now covered by UBS Group. They set a “buy” rating and a $109.00 price target on the stock. 10/15/2026 – Arrowhead Pharmaceuticals had its “buy” rating reaffirmed by Chardan Capital. They now have […]

A number of research firms have changed their ratings and price targets for LPL Financial (NASDAQ: LPLA): 10/29/2026 – LPL Financial had its price target lowered by UBS Group from $390.00 to $369.00. They now have a “buy” rating on the stock. 10/28/2026 – LPL Financial had its “buy” rating reaffirmed by The Goldman Sachs […]

Wise Group (NASDAQ: WSE) has recently received a number of price target changes and ratings updates: 10/17/2026 – Wise Group was downgraded by Wall Street Zen from “hold” to “sell”. 10/16/2026 – Wise Group was upgraded by Monness Crespi & Hardt to “strong-buy”. 10/16/2026 – Wise Group had its price target raised by JPMorgan Chase […]

Dutch Bros (NYSE: BROS) has recently received a number of price target changes and ratings updates: 10/30/2026 – Dutch Bros had its price target lowered by Mizuho from $80.00 to $65.00. They now have an “outperform” rating on the stock. 10/26/2026 – Dutch Bros had its price target lowered by UBS Group from $85.00 to […]

Several brokerages have updated their recommendations and price targets on shares of Albany International (NYSE: AIN) in the last few weeks: 10/31/2026 – Albany International was upgraded by Wall Street Zen from “buy” to “strong-buy”. 10/30/2026 – Albany International had its price target raised by JPMorgan Chase & Co. from $67.00 to $71.00. They now […]

RTX (NYSE: RTX) has recently received a number of price target changes and ratings updates: 10/22/2026 – RTX was upgraded by Weiss Ratings from “buy (b)” to “buy (a-)”. 10/21/2026 – RTX had its price target raised by UBS Group from $209.00 to $212.00. They now have a “neutral” rating on the stock. 10/21/2026 – […]

BrightSpire Capital (NYSE: BRSP) recently received a number of ratings updates from brokerages and research firms: 10/24/2026 – BrightSpire Capital was downgraded by Wall Street Zen from “hold” to “sell”. 10/14/2026 – BrightSpire Capital was downgraded by Zacks Research from “hold” to “strong sell”. 10/7/2026 – BrightSpire Capital had its “market outperform” rating reaffirmed by […]

A number of research firms have changed their ratings and price targets for Real REMAX Group (NASDAQ: REAX): 10/21/2026 – Real REMAX Group had its “neutral” rating reaffirmed by Zelman & Associates. 10/14/2026 – Real REMAX Group was given a new $40.00 price target by Compass Point. 10/14/2026 – Real REMAX Group is now covered […]

A number of research firms have changed their ratings and price targets for Viper Energy (NASDAQ: VNOM): 10/19/2026 – Viper Energy was upgraded by Wall Street Zen from “hold” to “buy”. 10/15/2026 – Viper Energy had its “hold (c)” rating reaffirmed by Weiss Ratings. 10/15/2026 – Viper Energy had its price target raised by Morgan […]

Several brokerages have updated their recommendations and price targets on shares of Candel Therapeutics (NASDAQ: CADL) in the last few weeks: 10/22/2026 – Candel Therapeutics is now covered by Jefferies Financial Group. They set a “buy” rating and a $25.00 price target on the stock. 10/22/2026 – Candel Therapeutics is now covered by Jefferies Financial […]

A number of research firms have changed their ratings and price targets for Vistra (NYSE: VST): 10/22/2026 – Vistra is now covered by HSBC. They set a “buy” rating and a $190.00 price target on the stock. 10/21/2026 – Vistra was given a new $176.00 price target by Raymond James Financial. 10/21/2026 – Vistra was […]

A number of firms have modified their ratings and price targets on shares of Plains GP (NYSE: PAGP) recently: 10/19/2026 – Plains GP had its “strong-buy” rating reaffirmed by Raymond James Financial. They now have a $30.00 price target on the stock. 10/19/2026 – Plains GP was downgraded by Zacks Research from “strong-buy” to “hold”. […]

A number of research firms have changed their ratings and price targets for Citizens (NASDAQ: CIZN): 10/19/2026 – Citizens had its “market outperform” rating reaffirmed by Citigroup. 10/13/2026 – Citizens is now covered by Citigroup. They set a “market outperform” rating on the stock. 10/12/2026 – Citizens was given a new $29.00 price target by […]

Wingstop (NASDAQ: WING) has recently received a number of price target changes and ratings updates: 10/22/2026 – Wingstop was given a new $180.00 price target by DA Davidson. 10/22/2026 – Wingstop had its price target lowered by Robert W. Baird from $160.00 to $150.00. They now have an “outperform” rating on the stock. 10/16/2026 – […]